TAK-218
TAK-218 is a promising candidate as an agent tor central nervous system trauma and ischemia. TAK-218 exhibits potent scavenging activity and antioxidative activity. TAK-218 also inhibits dopamine release[1].
Product Specifications
CAS Number
[156756-10-4]
UNSPSC
12352005
Target
Dopamine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/tak-218.html
Smiles
CC1=C2C(O[C@@](C)(C2)CN3CCC(C4=CC=CC=C4)CC3)=C(C(C)=C1N)C.Cl.Cl
Molecular Formula
C24H34Cl2N2O
Molecular Weight
437.45
References & Citations
[1]Morio MURAKAMI, et al. ESR Study on the Antioxidant Activity of TAK-218 in Biological Model Membranes. Chem. Pharm. Bull. 48 (6) 784-792 (2000) .
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1435706-01 0.02 mg (E-Coli)
Recombinant Clostridium acetobutylicum UPF0251 protein CA_C3166 (CA_C3166)
Ask
View Details 
MBS1435706-02 0.1 mg (E-Coli)
Recombinant Clostridium acetobutylicum UPF0251 protein CA_C3166 (CA_C3166)
Ask
View Details MBS1435706-03 0.02 mg (Yeast)
Recombinant Clostridium acetobutylicum UPF0251 protein CA_C3166 (CA_C3166)
Ask
View Details MBS1435706-04 0.1 mg (Yeast)
Recombinant Clostridium acetobutylicum UPF0251 protein CA_C3166 (CA_C3166)
Ask
View Details 
MBS1435706-05 0.02 mg (Baculovirus)
Recombinant Clostridium acetobutylicum UPF0251 protein CA_C3166 (CA_C3166)
Ask
View Details MBS1435706-06 0.02 mg (Mammalian-Cell)
Recombinant Clostridium acetobutylicum UPF0251 protein CA_C3166 (CA_C3166)
Ask
View Details